CJC-1295 / Ipamorelin
The classic pairing of a GHRH analog with a selective ghrelin agonist.
Get the full guide →Overview
This is a research blend of CJC-1295 and ipamorelin — the most-studied secretagogue combination — prepared together to investigate two complementary arms of growth-hormone-axis signaling.
Mechanism & receptor biology
CJC-1295 engages the GHRH receptor while ipamorelin engages the ghrelin / GHS receptor. The research rationale is to study how simultaneous stimulation of both pathways compares with either alone in model systems.
Research context
As a blend it has no single formula; each component is independently characterized. Handled strictly as research material.
Reference specifications
| Sequence | Two-peptide research blend |
|---|---|
| Molecular formula | Blend — see components |
| Molecular weight | — |
| CAS number | 863288-34-0 / 170851-70-4 |
CJC-1295 / Ipamorelin is offered strictly for laboratory and research use only. It is not a drug, supplement, or article of food, and is not intended to diagnose, treat, cure, or prevent any disease, nor for human or animal consumption. The information above is an educational summary of published receptor biology and does not constitute medical advice.
Related compounds in Growth Hormone & IGF-1 Axis
Get the full Peptide Research Guide
The complete reference — all 20 compound profiles, five research classes, receptor biology and laboratory-grade standards — plus a free reconstitution calculator, delivered as a PDF.
Get the free guide →